Company
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 25 of 29
Diamondcorp raises production in South Africa, Range Resources confirmed the spudding of its latest well in Trinidad and Utilitywise gets a new chief executive.
GoFigure products will initially be stocked in eight UK Whole Foods Market shops with opportunities for further expansion.
OptiBiotix Health appoints director of business, African Potash signs a deal with a distributor in Zambia and Proton Power Systems unveils a business overhaul.
Gosalbez may take on a board position within OptiBiotix's divisional structure as these develop into separate legal entities
Cello reports "noticeable impact" from Brexit, Tern reports a big jump in total assets, and Green Dragon has a production boost in China.
Carpet seller Victoria's results caught the eye, with revenue and adjusted EBITDA double what they were in the previous year
The JV will be used as an “incubator” for the technology to develop other functional foods that help tackle obesity.
Archive
The filing is for a combination of OptiBiotix's Lactobacillus plantarum strain
OptiBiotix is to create four separate operating divisions; Tavistock enjoyed a strong set of results; AdEPT recorded its 13th consecutive year of increased underlying earnings; and more…
OptiBiotix is about to enter a new growth phase, forming four divisions devoted to separate IP platforms
Treasury minister Jim O’Neill is proposing to tax big pharma to pay for much-needed R&D on the next generation of antibiotics.
Amur Minerals has pitched the potential of its Kun-Manie nickel project in Far East Russia to potential investors in Korea.
Pharma company shares rise as report urges action to develop super-bug treatments
Not content with fighting the modern day killers such as diabetes and obesity, OptiBiotix is aiming to tackle infections such as MRSA. And today it has filed for patents covering its new skin care technology.
The study of microbiomes is a hot area at the moment, and the US is ploughing US$500mln into research
Life sciences group OptiBiotix Health PLC has the platforms and partners in place to bring its products to market, reckons broker Hybridan. It has raised its value per share on the firm to 106p from a current price of around 81p.
Archive
Connemara Mining Company had more good news, Eland Oil & Gas Plc expects to complete flow testing and Fastjet halted its application for an air operator’s licence.
FTSE AIM All-share added 0.19% to 732.6, while FTSE100 was three points better at 6,367, another new high for the year.
